[1]
2023. Cardiac Magnetic Resonance Imaging In The Evaluation Of Patients With Valvular Heart Disease. Journal of Pharmaceutical Negative Results. (Jan. 2023), 1349–1367. DOI:https://doi.org/10.47750/pnr.2023.14.02.174.